As of 2023, Innovent Biologics has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 intensity-based target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Innovent Biologics ’s climate strategy, ambition level, and alignment with global decarbonization goals.
Target Type | Scope of Target | Unit | Target | Target Year |
---|---|---|---|---|
Intensity-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) per Unit of Other Product (Unlisted) Produced/Manufactured | Copy restricted. Please purchase to unlock this data. | 2030 |
This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
As of 2023, Innovent Biologics has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.
As of 2023, Innovent Biologics has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.
Innovent Biologics's most ambitious operational target is to reduce these emissions by 10% by 2030, compared to a baseline of 0.014 Metric Tonnes of CO2 equivalent (mtCO2e) per Unit of Other Product (Unlisted) Produced/Manufactured in 2020.
Innovent Biologics has already surpassed its operational emissions reduction target, with 2023 levels falling below the 2030 value, achieving its climate goal ahead of schedule.